Fibroblast Growth Factor 21 Drives Dynamics of Local and Systemic Stress Responses in Mitochondrial Myopathy with mtDNA Deletions
Saara Forsström(University of Helsinki), Anu Suomalainen(University of Helsinki), Vidya Velagapudi(University of Helsinki), Christopher J. Carroll(St George's, University of London), Nahid Khan(University of Helsinki), Anne Roivainen, Eija Pirinen(University of Helsinki), Swagat Pradhan(University of Helsinki), Mervi Kuronen(University of Helsinki), Anastasiia Marmyleva(University of Helsinki), Päivi Marjamäki(University of Turku), Iida-Marja Kleine(University of Helsinki), Christopher B. Jackson(Memorial Sloan Kettering Cancer Center), Joni Nikkanen(University of Helsinki), Mari Auranen(University of Helsinki), Liliya Euro(University of Helsinki), Uwe Richter(University of Helsinki), Heidi Liljenbäck(University of Turku), Liya Wang(Cold Spring Harbor Laboratory), Brendan J. Battersby(University of Helsinki)
Cited by 262
Related Papers
Mitochondrial diseases
|Nature Reviews Disease Primers|2016|1.5k
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420
Taurine deficiency as a driver of aging
|Science|2023|405
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386